Related Experiment Video
Updated: Oct 5, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
[Passive immunotherapy in Sars-Cov2 infections]
Ioanna Christodoulou1, Jacques H M Cohen2
1Institut Lavoisier de Versailles, UMR CNRS 8180, Université Paris-Saclay, Université de Versailles St-Quentin-en-Yvelines 78035 Versailles cedex, France.
This article presents the current situation by November 2021 of the prophylactic or therapeutical use of polyclonal or monoclonal antibodies in Covid-19, either as immuno-modulators, or directly directed towards the virus.
This article presents the current situation by November 2021 of the prophylactic or therapeutical use of polyclonal or monoclonal antibodies in Covid-19, either as immuno-modulators, or directly directed towards the virus.
Related Concept Videos
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Vaccinations

